Skip Navigation

NHLBI Strategic Visioning

Community Update Button

NHLBI Clinical Trials

Trustworthy guidelines should be based on a systematic evidence review, developed by panel of multidisciplinary experts, provide a clear explanation of the logical relationships between alternative care options and health outcomes, and provide ratings of both the quality of evidence and the strength of the recommendations.

NHLBI Systematic Evidence Reviews in development.

Funding Opportunities

Inside NHLBI

Featured Fact Sheet

Afia Donkor, a Candian woman who once live with sickle cell disease.

“Feels Like a Cure”: Sickle Cell Patient Triumphs after Experimental Bone Marrow Transplant

In 2010, Afia Donkor, a young woman from Canada, struggled to walk a few blocks from her home to a subway station in Montreal on her way to the airport. Suitcase in hand, she moved at a snail’s pace as she experienced severe exhaustion due to a flare-up of her sickle cell disease. One step at a time, she finally made it, propelled by the hope of a new treatment that awaited her at the other end of her journey to the United States. Read full fact sheet...

View All Fact Sheets

Dr. Michael Lauer to Depart the NHLBI and Assume Position of NIH Deputy Director for Extramural Research

Gary H. Gibbons, M.D.
September 28, 2015
It is with bittersweet emotion that I announce the departure of Dr. Michael S. Lauer, director of the Division of Cardiovascular Sciences (DCVS), from the NHLBI. We are proud and excited that NIH Director Dr. Francis Collins has selected Dr. Lauer to join his NIH leadership team as the next Deputy Director for Extramural Research and Director of the NIH Office of Extramural Research Activities.
View full message

View all Director's messages

Subscribe to receive "What's New" by email: